Vera Zdravkovic -End users and Open access in biomedical science

19
KORISNIK I OTVORENI PRISTUP Vera Zdravković 

description

Doctor Vera Zdravkovic presented how end users can manage with OA platforms, Open Access journals in medical practice

Transcript of Vera Zdravkovic -End users and Open access in biomedical science

Page 1: Vera Zdravkovic  -End users and Open access in biomedical science

KORISNIK I OTVORENI PRISTUP

Vera Zdravković 

Page 2: Vera Zdravkovic  -End users and Open access in biomedical science

KORISNIK

Ko su korisnici?

Lekari Istraživači Predavači Pacijenti/roditelji

Otvoreni pristup je posebno neophodan u zemlji kao Srbija

Page 3: Vera Zdravkovic  -End users and Open access in biomedical science
Page 4: Vera Zdravkovic  -End users and Open access in biomedical science

ČASOPISI SA SLOBODNIM PRISTUPOM

Medicina 314 Pedijatrija 43 Clinical Pediatric endocrinolgy (Japan) International Journal of Pediatric endocrinology 

(US) International Journal of Pediatrics (US)

Page 5: Vera Zdravkovic  -End users and Open access in biomedical science

POTREBA ZA INFORMACIJOM

U toku dežurstva dobijate poziv za konsultaciju Mlado muško odojče primljeno zbog izmenjenog 

stanje svesti Laboratorijske analize: nizak Na i visok K Treba da isključite adrenalnu insuficijenciju Ne postoje svi elementi kliničke slike Konsultujete Pubmed

Page 6: Vera Zdravkovic  -End users and Open access in biomedical science
Page 7: Vera Zdravkovic  -End users and Open access in biomedical science
Page 8: Vera Zdravkovic  -End users and Open access in biomedical science
Page 9: Vera Zdravkovic  -End users and Open access in biomedical science

International Journal of Pediatric EndocrinologyVolume 2009 (2009), Article ID 195728, 4 pagesdoi:10.1155/2009/195728Case Report

Transient Pseudohypoaldosteronism due to Urinary Tract Infection in Infancy: A Report of 4 CasesRadha Nandagopal,1 Priya Vaidyanathan,2 and Paul Kaplowitz2

1Inter-Institute Pediatric Endocrinology Training Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA2Department of Endocrinology, Children's National Medical Center, Washington, DC 20010, USA

Received 5 December 2008; Revised 10 March 2009; Accepted 23 April 2009

Academic Editor: Christa Flueck

Copyright © 2009 Radha Nandagopal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Page 10: Vera Zdravkovic  -End users and Open access in biomedical science

AbstractHyponatremia with hyperkalemia in infancy is an uncommon but life-threatening occurrence. In the first weeks of life, this scenario is often associated with aldosterone deficiency due to salt-wasting congenital adrenal hyperplasia. However, alternative diagnoses involving inadequate mineralocorticoid secretion or action must be considered, particularly for infants one month of age or older. We report four infants who presented with profound hyponatremia accompanied by urinary tract infection, ultimately leading to the diagnosis of transient pseudohypoaldosteronism. Our cases provide support for the idea that the renal tubular resistance to aldosterone is due to urinary tract infection itself rather than to underlying urinary tract anomalies typically found in these infants. Awareness of this condition is important so that serum aldosterone, urine sodium, and urine cultures may be obtained immediately in any infant presenting with hyponatremia and hyperkalemia in whom a diagnosis of congenital adrenal hyperplasia was not found. Adequate replacement with intravenous saline and antibiotic therapy is sufficient to correct sodium levels over 24–48 hours.

Page 11: Vera Zdravkovic  -End users and Open access in biomedical science

JOŠ JEDNA PRIMENA OA 

Saopštavanje važnih informacija javnosti

Page 12: Vera Zdravkovic  -End users and Open access in biomedical science

Neželjena dejstva leka

Inicijalno lečenje hipertireoize - lekovi

Propiltiouracil i metimazolski preparati

Poslednjih godina je prijavljeno 14 slučajeva insuficijencije jetre kod dece usled primene PTU

U registru pacijenata kojima je iz ovog razloga transplantirana jetra postoji 8 dece

Page 13: Vera Zdravkovic  -End users and Open access in biomedical science

ZAKLJUČAK WORKSHOPA ODRŽANOG 2008

Considering the above, we believe that PTU should never be used as first line treatment in children. PTU use should only be considered in rare circumstances, such as preparation for surgery in a patient allergic to MMI or in pregnancy.

Page 14: Vera Zdravkovic  -End users and Open access in biomedical science

PUBLIKACIJA ZAKLJUČAKA

Kako alarmirati javnost

S. Rivkees koji ima 140 radova na Pubmedu, u časopisima koji imaju IF i 50 se odlučuje za OA časopis

Page 15: Vera Zdravkovic  -End users and Open access in biomedical science

International Journal of Pediatric EndocrinologyVolume 2009 (2009), Article ID 132041, 8 pagesdoi:10.1155/2009/132041

Commentary

Propylthiouracil (PTU) Hepatoxicity in Children and Recommendations for Discontinuation of Use

Scott A. Rivkees1 and Donald R. Mattison2

1Yale Pediatric Thyroid Center, Yale University School of Medicine, New Haven, CT 06520, USA2Obstetric and Pediatric Pharmacology Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA

Received 5 April 2009; Accepted 7 April 2009

Izveštaj workshop-a koji je održan pod pokroviteljstvom Best Pharmaceuticals for Children Act, oktobra 2008 da bi se procenila bezbednost primene PTU kod dece

Page 16: Vera Zdravkovic  -End users and Open access in biomedical science
Page 17: Vera Zdravkovic  -End users and Open access in biomedical science

THE PUBLIC LIBRARY OF SCIENCE (PLOS)

Veliki neprofitni izdavač po principu otvorenog pristupa

Izdaje 7 časopisa, do kojih je jedan PLoS Medicine

Page 18: Vera Zdravkovic  -End users and Open access in biomedical science

PLOS MEDICINE Široka dostupnost

Brze i profesionalne recenzije (peer review)

Mogućnost upita pre slanja članka (ogovor u roku od 48h)

Brza publikacija, prosečno oko 6 nedelja

Izdavačev komentar

Author- može sam da edituje tekst

Nije potrebno naručivati reprinte

Mogućnost postizanja velikog impakt faktora

Publicitet

Beleške, komentari and ocenjivanje

Page 19: Vera Zdravkovic  -End users and Open access in biomedical science

IMPACT FACTOR - METRICS